FDA Adds Its Strongest Warning to a Common IV Iron Drug Over Dangerously Low Phosphate Levels

FDA added a boxed warning to Injectafer over symptomatic hypophosphatemia after finding that phosphate testing occurs in under 20% of infusions.

Have A Referral?